Klaus Moosmayer joined Novartis in 2018 as Chief Ethics, Risk and Compliance Officer and a member of the Executive Committee. He was previously chief compliance officer at Siemens AG, where he spent 18 years in roles of increasing seniority. He began his career as a lawyer in Germany, specializing in white-collar crime, business law and litigation. In this episode we explore the reality of ethical dilemmas in the corporate world, the importance of building trust, especially in the pharmaceutical industry, and the value of creating an inviting atmosphere for discussions on ethics and compliance. Klaus also discusses the development of a new code of ethics at Novartis – likening it to the company's constitution. Links Mentioned: Cultureandleadership.org ‘Blind Spots’ by Ann Tenbrunsel and Max Bazerman Klaus Moosmayer on LinkedIn